Why the study?
Although acute heart failure compromises clinical results after valve surgery for infective endocarditis, little is known regarding outcomes in patients with cardiogenic shock.
Does valve surgery in infective endocarditis patients with cardiogenic shock have comparable outcomes to those with non-cardiogenic shock acute heart failure?
Does valve surgery in infective endocarditis patients with cardiogenic shock have comparable outcomes to those with non-cardiogenic shock acute heart failure?
Valve surgery for active infective endocarditis complicated by cardiogenic shock yields acceptable mid-term survival that is comparable to patients with non-shock acute heart failure.
BACKGROUND: Infective endocarditis remains associated with substantial mortality and morbidity rates, and the presence of acute heart failure (AHF) compromises clinical results after valve surgery; however, little is known in cardiogenic shock (CGS) patients. This study evaluated the clinical results and risk of mortality in CGS patients after valve surgery. METHODS AND RESULTS: This study enrolled 585 patients who underwent valve surgery for active endocarditis at 14 institutions between 2009 and 2017. Of these patients, 69 (12%) were in CGS, which was defined as systolic blood pressure <80 mmHg and severe pulmonary congestion, requiring mechanical ventilation and/or mechanical circulatory support, preoperatively. The predictors of CGS were analyzed, and clinical results of patients with non-CGS AHF (n=215) were evaluated and compared.Staphylococcus aureusinfection (odds ratio [OR] 2.19; P=0.044), double valve involvement (OR 3.37; P=0.003), and larger vegetation (OR 1.05; P=0.036) were risk factors for CGS. Hospital mortality occurred in 27 (13%) non-CGS AHF patients and in 15 (22%) CGS patients (P=0.079). Overall survival at 1 and 5 years in CGS patients was 76% and 69%, respectively, and there were no significant differences in overall survival compared with non-CGS AHF patients (P=1.000). CONCLUSIONS: Clinical results after valve surgery in CGS patients remain challenging; however, mid-term results were equivalent to those of non-CGS AHF patients.
No takes yet. Share an insight, caveat, or question.
Handa et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: